Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK RENI KLAVSEN D.C. ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.6% 6.9% 8.4% 4.8% 3.6% 3.5% 13.2% 12.9%   Credit score (0-100)   47 36 29 43 52 52 17 18   Credit rating   BBB BBB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,140 1,067 1,157 1,376 1,284 1,279 0.0 0.0   EBITDA   668 221 582 825 689 701 0.0 0.0   EBIT   583 143 581 825 664 600 0.0 0.0   Pre-tax profit (PTP)   578.0 127.0 555.0 852.0 632.0 637.9 0.0 0.0   Net earnings   451.0 98.0 432.0 662.0 491.0 497.5 0.0 0.0   Pre-tax profit without non-rec. items   578 127 555 852 632 638 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   79.0 1.0 0.0 0.0 480 379 0.0 0.0   Shareholders equity total   1,495 1,192 1,224 1,486 1,577 1,675 1,150 1,150   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,618 1,305 1,518 1,684 1,696 1,879 1,150 1,150   Net Debt   -1,332 -1,124 -1,490 -1,478 -997 -1,360 -1,150 -1,150     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,140 1,067 1,157 1,376 1,284 1,279 0.0 0.0   Gross profit growth   -9.3% -6.4% 8.4% 18.9% -6.7% -0.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,618 1,305 1,518 1,684 1,696 1,879 1,150 1,150   Balance sheet change%   3.3% -19.3% 16.3% 10.9% 0.7% 10.8% -38.8% 0.0%   Added value   668.0 221.0 582.0 825.0 664.0 700.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -170 -156 -2 0 455 -202 -379 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.1% 13.4% 50.2% 60.0% 51.7% 46.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.6% 9.8% 41.2% 54.5% 39.3% 35.8% 0.0% 0.0%   ROI %   39.7% 10.6% 48.1% 64.4% 42.9% 38.6% 0.0% 0.0%   ROE %   30.7% 7.3% 35.8% 48.9% 32.1% 30.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   92.4% 91.3% 80.6% 88.2% 93.0% 89.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -199.4% -508.6% -256.0% -179.2% -144.7% -194.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   11.0 10.9 5.2 7.6 13.2 8.1 0.0 0.0   Current Ratio   11.0 10.9 5.2 7.6 13.2 8.1 0.0 0.0   Cash and cash equivalent   1,332.0 1,124.0 1,490.0 1,478.0 997.0 1,359.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,234.0 1,084.0 1,205.0 1,264.0 941.0 1,112.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   668 221 582 825 664 701 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   668 221 582 825 689 701 0 0   EBIT / employee   583 143 581 825 664 600 0 0   Net earnings / employee   451 98 432 662 491 498 0 0